Janet K. Cheetham

Report From the NEI/FDA Endpoints Workshop on Age-Related Macular Degeneration and Inherited Retinal Diseases

Karl G. Csaky, Frederick L. Ferris, Emily Y. Chew et al. · Investigative Ophthalmology & Visual Science · 2017 · 216 citations · Full text

Ocular Disease, Retina, Ophthalmology +8

Brimonidine and Timolol Fixed-Combination Therapy Versus Monotherapy: A 3-Month Randomized Trial in Patients with Glaucoma or Ocular Hypertension

E. Randy Craven, Thomas R. Walters, Robert D. Williams et al. · Journal of Ocular Pharmacology and Therapeutics · 2005 · 79 citations

Double-Masked, Randomized, Phase 2 Evaluation of Abicipar Pegol (an Anti-VEGF DARPin Therapeutic) in Neovascular Age-Related Macular Degeneration

David Callanan, Derek Kunimoto, Raj K. Maturi et al. · Journal of Ocular Pharmacology and Therapeutics · 2018 · 74 citations · Full text

Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery:

Jeff Heier, Janet K. Cheetham, Ronald E. DeGryse et al. · American Journal of Ophthalmology · 1999 · 69 citations

Ophthalmic Surgery, Ocular Disease, Ocular Inflammation +7

Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients

Kerry D. Solomon, Eric D. Donnenfeld, Michael B. Raizman et al. · Journal of Cataract & Refractive Surgery · 2004 · 64 citations